Cargando…
Antidepressant therapy with milnacipran and venlafaxine
Specific serotonin norepinephrine reuptake inhibitors (SNRIs) have been described as “better tolerated tricyclic antidepressants” or as “boosted” selective serotonin reuptake inhibitors (SSRIs). Venlafaxine has become a therapeutic reference treatment for major depression. Although less widely studi...
Autor principal: | Mansuy, Lucilla |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819762/ http://dx.doi.org/10.2147/NDT.S11776 |
Ejemplares similares
-
Milnacipran: a unique antidepressant?
por: Kasper, Siegfried, et al.
Publicado: (2010) -
Milnacipran for the management of fibromyalgia syndrome
por: Ormseth, Michelle J, et al.
Publicado: (2010) -
Modulation of microglial function by the antidepressant drug venlafaxine
por: Dubovický, Michal, et al.
Publicado: (2014) -
Recent Advances in the Electrochemical Sensing of Venlafaxine: An Antidepressant Drug and Environmental Contaminant
por: Tajik, Somayeh, et al.
Publicado: (2020) -
Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran
por: Courtet, Philippe
Publicado: (2010)